Quent Capital’s NeuroOne Medical Technologies NMTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6 Hold
6
– – ﹤0.01% 1664
2026
Q2
$18 Sell
6
-1
-14% -$4 ﹤0.01% 1645
2026
Q1
$31 Hold
7
– – ﹤0.01% 1525
2025
Q4
$30 Hold
7
– – ﹤0.01% 1559
2025
Q3
$36 Buy
+7
New +$34 ﹤0.01% 1416

Other funds holding NMTC

Quent Capital's NMTC Position: Q3 2026 in Review

Quent Capital held its NeuroOne Medical Technologies (NMTC) position steady in Q3 2026 at 6 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Quent Capital first reported a position in NMTC in Q3 2025 and has held it in 5 quarters since. The position peaked at $36 in Q3 2025. 24 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

  • Quent Capital held 6 shares of NeuroOne Medical Technologies worth $6 as of Q3 2026.
  • Quent Capital left its NeuroOne Medical Technologies share count unchanged in Q3 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1664 holding.
  • Quent Capital first reported a position in NeuroOne Medical Technologies in Q3 2025 and has held it in 5 quarters since.
  • Quent Capital's NeuroOne Medical Technologies position peaked at $36 in Q3 2025.
  • 24 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.